ATE494375T1 - Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen - Google Patents

Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen

Info

Publication number
ATE494375T1
ATE494375T1 AT05008181T AT05008181T ATE494375T1 AT E494375 T1 ATE494375 T1 AT E494375T1 AT 05008181 T AT05008181 T AT 05008181T AT 05008181 T AT05008181 T AT 05008181T AT E494375 T1 ATE494375 T1 AT E494375T1
Authority
AT
Austria
Prior art keywords
nucleotide sequences
compositions
expression products
frazzled
frazzled nucleotide
Prior art date
Application number
AT05008181T
Other languages
English (en)
Inventor
Hazel Sive
Benjamin Sun
Lisa A Racie
Edward R Lavallie
Janet E Paulsen
Original Assignee
Genetics Inst Llc
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc, Whitehead Biomedical Inst filed Critical Genetics Inst Llc
Application granted granted Critical
Publication of ATE494375T1 publication Critical patent/ATE494375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT05008181T 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen ATE494375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/893,654 US6165748A (en) 1997-07-11 1997-07-11 Frazzled nucleotide sequences and expression products

Publications (1)

Publication Number Publication Date
ATE494375T1 true ATE494375T1 (de) 2011-01-15

Family

ID=25401869

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98920893T ATE313627T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
AT05008181T ATE494375T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98920893T ATE313627T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen

Country Status (8)

Country Link
US (1) US6165748A (de)
EP (2) EP1591526B1 (de)
JP (2) JP2001509382A (de)
AT (2) ATE313627T1 (de)
AU (1) AU751803B2 (de)
DE (2) DE69832880T2 (de)
MX (1) MXPA00001427A (de)
WO (1) WO1999002679A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673909B1 (en) * 1998-08-25 2004-01-06 The General Hospital Corporation Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
US20030187054A1 (en) * 2000-03-10 2003-10-02 Shunsuke Nagao Preparations for chondrogenesis
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US20030044409A1 (en) * 2001-05-01 2003-03-06 Carson Dennis A. Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
US7682607B2 (en) * 2001-05-01 2010-03-23 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
CA2570407C (en) * 2003-06-25 2014-01-07 Ottawa Health Research Institute Methods and compositions for modulating stem cell growth and differentiation
WO2007101063A2 (en) 2006-02-22 2007-09-07 Zhu M D Zhenglun Treatment of development-related disorders
WO2007124448A2 (en) * 2006-04-20 2007-11-01 Rosero Spencer Z Method and apparatus for the management of diabetes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
DE3382562D1 (de) 1982-09-24 1992-06-25 Us Health Wiederherstellung von gewebe bei tieren.
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
IE60819B1 (en) 1984-07-06 1994-08-10 Sandoz Ltd Lymphokine production and purification
DE3586386T2 (de) 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US5646016A (en) 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
DK0605428T5 (da) 1991-06-24 2003-01-06 Hcell Technology Inc Hormonsecernerende pancreasceller opretholdt i langtidskultur
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
WO1998016641A1 (en) * 1996-10-11 1998-04-23 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Isolation and method of using tissue growth-inducing frzb protein

Also Published As

Publication number Publication date
WO1999002679A1 (en) 1999-01-21
JP2001509382A (ja) 2001-07-24
EP1000143B1 (de) 2005-12-21
EP1000143A1 (de) 2000-05-17
AU751803B2 (en) 2002-08-29
DE69832880T2 (de) 2006-06-22
MXPA00001427A (es) 2005-01-25
EP1591526A2 (de) 2005-11-02
DE69832880D1 (de) 2006-01-26
US6165748A (en) 2000-12-26
AU7363198A (en) 1999-02-08
EP1591526A3 (de) 2007-08-08
ATE313627T1 (de) 2006-01-15
EP1591526B1 (de) 2011-01-05
DE69842091D1 (de) 2011-02-17
JP2009142287A (ja) 2009-07-02

Similar Documents

Publication Publication Date Title
HK1046004A1 (en) Recombinant gelatins
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DK0996430T3 (da) Nukleotidanalogsammensætninger
TR199800375A3 (tr) Selant kompozisyonlari.
ID23374A (id) Halogenopirimidin
BR9813569B1 (pt) processo, e, composiÇço de aditivo alimentÍcio.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
ZA981017B (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.
TR199501650A2 (tr) Agiz bilesimleri.
ATE494375T1 (de) Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen
TR199501645A2 (tr) Agiz bilesimleri.
BR9916537B1 (pt) composição de fragráncia, e, produto.
AU6849198A (en) Neurotrypsin
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ITBZ950006V0 (it) Guarnitura per mobili.
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
TR199902434T2 (xx) Bakteriyel plazmidler.
DE69720043D1 (de) Enzymatische bleichmittelzusammensetzung
PE20399A1 (es) Muteina ob
IT242987Y1 (it) Guarnitura per mobili.
TR199501649A2 (tr) Agiz bilesimleri.
ATE321768T1 (de) Linker-nucleosid, seine herstellung und verwendung
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties